Olema Pharmaceuticals Inc (OLMA)
Healthcare
Biotechnology
11.50 $
-3.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Olema Pharmaceuticals Inc (OLMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -46 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22 | -23 | -18 | -23 | -28 | -27 | -26 | -44 | -30 | -35 | -38 | -46 | -149 | |
| 0.4 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.2 | 0.1 | 0.5 | |
| 4.2 | 4.1 | 4.4 | 4.9 | 5.7 | 5.6 | 6.3 | 4.4 | 4.7 | 4.3 | 4.3 | 10 | 23 | |
| 4.2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -5.5 | -4.6 | 5.8 | 4.5 | -1.1 | 3.5 | 2.2 | -16 | 11 | 4.4 | 4.1 | -2.2 | 17 | |
| 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 14 | -25 | -31 | -20 | -4.9 | 46 | -114 | -45 | 34 | 17 | -162 | 4.5 | -106 | |
| 2.0 | – | – | – | – | 0.7 | – | – | 0.7 | – | 0.3 | – | – | |
| – | – | – | – | – | 0.0 | – | – | – | 0.0 | 0.0 | – | – | |
| 2.0 | 131 | 0.5 | 8.8 | 16 | 0.1 | 244 | 0.2 | -2.5 | 0.0 | 214 | 46 | 257 | |
| -6.0 | 82 | -49 | -35 | -17 | 19 | 104 | -89 | 1.8 | -17 | 13 | 4.2 | 1.9 | |
| -22 | -23 | -18 | -24 | -28 | -27 | -26 | -44 | -30 | -35 | -38 | -46 | -149 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.